Teladoc Historical Financial Ratios
| TDOC Stock | USD 8.73 0.32 3.80% |
Teladoc is promptly reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 8.3, Free Cash Flow Yield of 0.19, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.81 will help investors to properly organize and evaluate Teladoc financial condition quickly.
Teladoc |
About Teladoc Financial Ratios Analysis
TeladocFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Teladoc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Teladoc financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Teladoc history.
Teladoc Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Teladoc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Teladoc sales, a figure that is much harder to manipulate than other Teladoc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most ratios from Teladoc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Free Cash Flow Yield is projected to increase slightly based on the last few years of reporting. The current year's Operating Cash Flow Per Share is expected to grow to 1.81, whereas Price To Sales Ratio is forecasted to decline to 0.57.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 31.93 | 32.27 | 31.81 | 46.84 | PTB Ratio | 1.65 | 1.5 | 1.04 | 0.99 |
Teladoc fundamentals Correlations
Click cells to compare fundamentals
Teladoc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teladoc fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 16.54 | 7.09 | 1.59 | 1.34 | 0.6 | 0.57 | |
| Ptb Ratio | 1.14 | 0.9 | 1.65 | 1.5 | 1.04 | 0.99 | |
| Days Sales Outstanding | 56.48 | 30.34 | 31.93 | 32.27 | 31.81 | 46.84 | |
| Book Value Per Share | 175.49 | 102.24 | 14.29 | 14.34 | 8.74 | 8.3 | |
| Free Cash Flow Yield | (0.004396) | 0.009025 | 0.004328 | 0.0554 | 0.18 | 0.19 | |
| Operating Cash Flow Per Share | (0.59) | 1.24 | 1.17 | 2.16 | 1.72 | 1.81 | |
| Stock Based Compensation To Revenue | 0.43 | 0.15 | 0.0905 | 0.0774 | 0.0568 | 0.088 | |
| Pb Ratio | 1.14 | 0.9 | 1.65 | 1.5 | 1.04 | 0.99 | |
| Ev To Sales | 17.21 | 7.27 | 1.86 | 1.52 | 0.71 | 0.68 | |
| Free Cash Flow Per Share | (0.88) | 0.83 | 0.1 | 1.19 | 1.66 | 1.74 | |
| Roic | (0.0202) | (0.0153) | 3.33 | (0.0626) | (0.4) | (0.38) | |
| Net Income Per Share | (5.36) | (2.73) | (84.6) | (1.36) | (5.87) | (6.16) | |
| Days Of Inventory On Hand | 52.76 | 41.02 | 27.64 | 14.17 | 18.53 | 12.33 | |
| Payables Turnover | 8.49 | 13.76 | 15.6 | 17.42 | 22.68 | 20.31 | |
| Sales General And Administrative To Revenue | 0.46 | 0.22 | 0.19 | 0.18 | 0.17 | 0.16 | |
| Capex To Revenue | 0.0238 | 0.0315 | 0.0718 | 0.0601 | 0.004199 | 0.003989 | |
| Cash Per Share | 8.69 | 5.71 | 5.69 | 6.93 | 7.61 | 4.1 | |
| Pocfratio | (338.22) | 74.28 | 20.17 | 9.98 | 5.28 | 5.54 | |
| Interest Coverage | (6.91) | (2.97) | 1.4K | (11.15) | (42.89) | (40.74) | |
| Capex To Operating Cash Flow | (0.49) | 0.33 | 0.91 | 0.45 | 0.0367 | 0.0386 | |
| Pfcf Ratio | (227.5) | 110.8 | 231.03 | 18.04 | 5.48 | 5.75 | |
| Days Payables Outstanding | 42.99 | 26.53 | 23.4 | 20.96 | 16.1 | 31.53 | |
| Income Quality | 0.11 | (0.45) | (0.0139) | (1.59) | (0.29) | (0.28) | |
| Roe | (0.0305) | (0.0267) | (5.92) | (0.0947) | (0.67) | (0.71) | |
| Ev To Operating Cash Flow | (351.89) | 76.21 | 23.63 | 11.32 | 6.25 | 6.57 | |
| Pe Ratio | (37.31) | (33.61) | (0.28) | (15.86) | (1.55) | (1.63) | |
| Return On Tangible Assets | (0.42) | (0.32) | (9.52) | (0.13) | (0.56) | (0.58) | |
| Ev To Free Cash Flow | (236.7) | 113.68 | 270.67 | 20.46 | 6.49 | 4.19 | |
| Earnings Yield | (0.0268) | (0.0298) | (3.58) | (0.0631) | (0.65) | (0.68) | |
| Intangibles To Total Assets | 0.94 | 0.93 | 0.67 | 0.63 | 0.49 | 0.52 | |
| Net Debt To E B I T D A | (1.67) | (4.42) | (0.049) | 3.04 | (0.49) | (0.46) | |
| Current Ratio | 3.19 | 3.7 | 3.29 | 3.54 | 1.77 | 1.68 | |
| Tangible Book Value Per Share | (7.94) | (2.35) | (3.73) | (2.62) | (1.31) | (1.38) | |
| Receivables Turnover | 6.46 | 12.03 | 11.43 | 11.31 | 11.47 | 7.26 | |
| Shareholders Equity Per Share | 175.49 | 102.24 | 14.29 | 14.34 | 8.74 | 8.3 | |
| Debt To Equity | 0.46 | 0.0923 | 0.079 | 0.68 | 1.06 | 1.12 | |
| Capex Per Share | 0.29 | 0.41 | 1.07 | 0.96 | 0.0633 | 0.0601 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.87) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.